Telangana Drugs Control Administration raided a quack's clinic at Medaram Village in the Mulugu District of the State and seized drugs stocked for sale. The DCA said that its team recovered 35 varieties of medicines, including antibiotics, steroids, and analgesics, from his clinic.
In a crackdown on unauthorized medicine sales, the Drugs Control Administration (DCA) of Telangana conducted a raid on an unlicensed godown in Uppal Khalsa, Medchal-Malkajgiri District, The raid resulted in the seizure of illegally stocked medicines worth Rs. 6.70 lakhs, according to a press
The project titled ' nPROUD' (New Programme for Removal of Unused Drugs) will be inaugurated by Health Minister Veena George on February 22 in Kozhikode.
In a decisive action against the illicit trade of spurious drugs, a joint investigation was conducted by the Central Drugs Standard Control Organization (CDSCO), East Zone, and the Drugs Control Directorate, West Bengal, at a wholesale premises in Kolkata, according to an official press rele
The Drugs Controller General of India (DCGI) has reduced the time required for blood bank licensing from a year to a maximum of four months by transitioning the entire process to a digital platform.
The Drugs Control Administration (DCA) of Telangana has raided a quack's clinic in Kakarvai village at Telangana's Khammam, and seized a stock of drugs being sold without a valid drug licence.
The search operation was conducted in private hospitals including the Bakoban Hospital, Chandrayangutta, Hyderabad and BVK Reddy Hospital, Warasiguda, Boudhnagar, Secunderabad.
Drugs Controller General of India (DCGI) Dr Rajeev Raghuvanshi, has said that 11 countries in the world have recognised Indian pharmacopoeia as their standard.
As per senior official sources, the DCGI is actively taking action against manufacturing companies producing drugs that do not meet the required standards of quality (NSQ). This proactive approach aims to protect public health and maintain trust in the healthcare system.
The Drugs Controller General of India (DCGI) on Wednesday suspended the product PresVu produced by Entod Pharmaceuticals after the company failed to respond to the queries on the product for which the DGCI says no approval was granted.